Patent · US Active

Genome editing using Campylobacter jejuni CRISPR/CAS system-derived RGEN

US10519454B2 · kind B2 · utility

1Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 31, 2017
Grant dateDec 31, 2019
Priority date—
Expiry dateMar 3, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure provided herewith relates to a Campylobacter jejuni CRISPR/CAS system-derived RGEN and a use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.